KR790001648B1 - Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives - Google Patents

Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives Download PDF

Info

Publication number
KR790001648B1
KR790001648B1 KR7601065A KR760001065A KR790001648B1 KR 790001648 B1 KR790001648 B1 KR 790001648B1 KR 7601065 A KR7601065 A KR 7601065A KR 760001065 A KR760001065 A KR 760001065A KR 790001648 B1 KR790001648 B1 KR 790001648B1
Authority
KR
South Korea
Prior art keywords
ethanol
hydrochloride
added
minutes
deriyatives
Prior art date
Application number
KR7601065A
Other languages
Korean (ko)
Inventor
히로무 무라이
요시아끼 아오야기
Original Assignee
모리시다 히로시
닛뽄 신야구 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모리시다 히로시, 닛뽄 신야구 가부시기가이샤 filed Critical 모리시다 히로시
Priority to KR7601065A priority Critical patent/KR790001648B1/en
Application granted granted Critical
Publication of KR790001648B1 publication Critical patent/KR790001648B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Title compds. (I; A = CH2CH(X)OH, -CH2CHCH2O(X = H, lower alkyl, oxymethyl, phenyl, or phen- oxymethyl)) were prepd. by the reaction of II with epoxy. Thus, 34g II. HC1 was soluted in 500ml C2H5OH contg. 5.0g metal Na and C2H5OH removed under reduced presure and then 15g β-bromo hydrine and 15g CaCO3 were added to said residue in 150ml DMF and stirred at 80-90≰C for 3hr to give I.

Description

트리메톡시 벤질 피페라지노 에탄올 유도체의 제조방법Method for preparing trimethoxy benzyl piperazino ethanol derivative

본 발명은 다음 일반식(I)로 표시된 트리메톡시벤질피페라지노 에탄올 유도체의 제조방법에 관한 것이다.The present invention relates to a method for preparing trimethoxybenzylpiperazino ethanol derivative represented by the following general formula (I).

Figure kpo00001
Figure kpo00001

(식중, A는

Figure kpo00002
혹은
Figure kpo00003
(Where A is
Figure kpo00002
or
Figure kpo00003

그중 X는 수소, 저급알킬기, 옥시메틸기, 페닐기 또는 펜옥시 메틸기임)X is hydrogen, lower alkyl group, oxymethyl group, phenyl group or phenoxy methyl group)

본 발명 화합물은 문헌 미재의 신규 물질로서 관상 동맥 혈관 확장작용, 심운동 억제 작용등의 관순환계에 대하여 유용한 약리 작용을 나타낸다.The compound of the present invention is a novel substance in the literature, and exhibits useful pharmacological action against the circulatory system such as coronary vasodilation and cardiomotor inhibition.

이들 약리작용의 일예로서, 몰못트 적출심장에 있어서의 란겐도르프(Langendorff)법에 의한 심장맥관에 대한 활성, 및 마우스에 대한 LD50치를 제1표에 표시한다.As an example of these pharmacological actions, the cardiovascular activity by the Langendorff method in the molar extract heart and LD 50 values for mice are shown in the first table.

[제 1 표][Table 1]

Figure kpo00004
Figure kpo00004

본 발명에 포함된 화합물은 어느 것이든 여러가지 방법에 의하여 합성이 가능하지만 가장 일반적이며 간편한 것은 다음의 화학 구조식(Ⅱ)로 표시된Compounds included in the present invention can be synthesized by any of a variety of methods, but the most common and convenient is represented by the following chemical formula (II)

Figure kpo00005
Figure kpo00005

트리메타디진에 각종의 에폭시 화합물을 반응시킴으로써 합성할 수 있다.It can synthesize | combine by making various epoxy compounds react with trimetadiazine.

그 외에, 구조식(Ⅱ) 화합물에 할로히드린을 작용시키는 N-알킬화법, 또는 피페라지노 에탄올류에 트리메톡시 벤질화를 행하는 방법도 유리하다. 또한 상기의 방법외에도 에탄올 아민류를 사용하는 피페라진 폐환법과 구조식(Ⅱ) 화합물을 먼저 α-할로카르보닐 화합물과 반응시킨 후, 환원하는 방법 등에 의해서도 합성하는 것이 가능하다.In addition, the N-alkylation method which makes a halohydrin act on a compound of formula (II), or the method of performing trimethoxy benzylation on piperazino ethanol is also advantageous. In addition to the above method, the piperazine cyclization method using ethanol amines and the structural formula (II) compound can be synthesized by first reacting with the α-halocarbonyl compound and then reducing.

이하 실시예에 의해 더욱 구체적으로 설명한다.It will be described in more detail by the following examples.

[실시예 1] (A : -CH2CH2OH)Example 1 (A: -CH 2 CH 2 OH)

화합물(Ⅱ)의 염산염(융점 215-222℃) 34g을 금속나트륨 5.0g을 용해한 에탄올 500ml에 가온 용해하고, 냉후 불용물을 여거하고 에탄올을 완전히 감압 유거한다. 잔류물을 DMF 150ml에 용해하고 β-브로모히드린 15g을 가하고, 다시 무수탄산칼륨 15g을 가하여 80-90℃로 3시간 가온 교반하고, 냉후 물로 희석하여 초산에틸로 추출하고 추출물을 염산염으로 하여 에탄올로 재결정한다.34 g of hydrochloride (melting point 215-222 ° C.) of compound (II) was dissolved in 500 ml of ethanol in which 5.0 g of metallic sodium was dissolved. The residue was dissolved in 150 ml of DMF, 15 g of β-bromohydrin was added thereto, and 15 g of anhydrous potassium carbonate was added thereto, followed by warming and stirring at 80-90 ° C. for 3 hours. After cooling, the mixture was diluted with water and extracted with ethyl acetate. Recrystallize with.

융점 220-225℃, 수득량 27.8gMelting point 220-225 ° C., yield 27.8 g

[실시예 2] (A : -CH2CH2OH)Example 2 (A: -CH 2 CH 2 OH)

화합물(Ⅱ)의 염산염 10g을 트리에틸아민 7.5g을 함유한 에탄올 50ml 중에 가하여 30분간 교반 환류하고, 냉후 아틸렌 옥사이드 2.0g을 함유한 에탄올 34ml를 빙냉 교반하 10분간에 적하하고, 실온에서 3시간 교반한다.10 g of hydrochloride of compound (II) was added to 50 ml of ethanol containing 7.5 g of triethylamine, and the mixture was stirred under reflux for 30 minutes. After cooling, 34 ml of ethanol containing 2.0 g of atylene oxide was added dropwise in 10 minutes under ice-cooling stirring, and 3 at room temperature. Stir for time.

에탄올을 감압하 유거하고, 잔류물을 실시예 1과 동일하게 처리하여 목적 물질의 염산염 8.8g을 얻었다.Ethanol was distilled off under reduced pressure, and the residue was treated in the same manner as in Example 1 to obtain 8.8 g of hydrochloride of the target substance.

[실시예 3] (A : -CH2CH2OH)Example 3 (A: -CH 2 CH 2 OH)

2,3,4-트리메톡시 벤즈알데히드 45g, N-β-하이드록시에틸 피페라진 30g을 에탄올 200ml중 30분간 가열 교반하고, 냉후 교반하 수소화 붕소나트륨 5.0g을 2시간 동안 가하여 환원한다.45 g of 2,3,4-trimethoxy benzaldehyde and 30 g of N-β-hydroxyethyl piperazine are heated and stirred in 200 ml of ethanol for 30 minutes, and 5.0 g of sodium borohydride is added for 2 hours while cooling, followed by reduction.

이하 실시예 1에 준하여 처리하여 목적 물질의 염산염 41g을 얻었다.41 g of the hydrochloride salt of the target substance was obtained by following the same procedure as in Example 1.

[실시예 4] (A : -CH2CH2OH)Example 4 (A: -CH 2 CH 2 OH)

2,3,4-트리메톡시벤즈 알데히드 19.6g 및 N-β-하이드록시 에틸 피페라진 19.5g을 에탄올 100ml 중에서 환류하 개미산 10ml을 가하여 6시간 환류한다. 이하 상법에 따라 처리하여 목적 물질의 염산염 17.0g을 얻는다.19.6 g of 2,3,4-trimethoxybenzaldehyde and 19.5 g of N-β-hydroxy ethyl piperazine are refluxed for 6 hours by adding 10 ml of formic acid under reflux in 100 ml of ethanol. Treatment is carried out according to the conventional method below to obtain 17.0 g of hydrochloride of the desired substance.

[실시예 5] (A : -CH2CH2OH)Example 5 (A: -CH 2 CH 2 OH)

2,3,4-트리메톡시벤질 클로라이드 4.33g, N-β-하이드록시에틸 피페라진 3.0g을 에탄올 50ml중에 가하고, 탄산칼륨 2.0g을 가하여 6시간 교반하고, 환류한다. 이하 상법에 따라 처리하여 목적물질의 염산염 3.3g을 얻는다.4.33 g of 2,3,4-trimethoxybenzyl chloride and 3.0 g of N-β-hydroxyethyl piperazine are added to 50 ml of ethanol, 2.0 g of potassium carbonate is added, stirred for 6 hours, and refluxed. The procedure is followed according to the conventional method to obtain 3.3 g of hydrochloride of the target substance.

[실시예 6] (A : -CH2CH2OH)Example 6 (A: -CH 2 CH 2 OH)

N, N-비스-β-클로로에틸-2,3,4-트리메톡시벤질아민 염산염(융점 127-131℃) 50g 및 모노에탄올아민 50g을 에탄올 150ml 중에서 1시간 30분 가열 환류한다. 이하 상법에 따라 처리하여 목적물질의 염산염 32g을 얻는다.50 g of N, N-bis-β-chloroethyl-2,3,4-trimethoxybenzylamine hydrochloride (melting point 127-131 ° C) and 50 g of monoethanolamine were heated to reflux for 1 hour 30 minutes in 150 ml of ethanol. Treated according to the conventional method below to obtain 32 g of hydrochloride of the target substance.

[실시예 7]

Figure kpo00006
Example 7
Figure kpo00006

에탄올 100ml 중에 금속 나트륨 1.33g을 용해하고, 화합물(Ⅱ)의 염산염 10g을 가하여 30분간 교반한다. 그후 프로필렌옥사이드 2.5g을 5분간에 적하하고, 1시간 가열 환류한다.1.33 g of metallic sodium is dissolved in 100 ml of ethanol, and 10 g of hydrochloride of compound (II) is added and stirred for 30 minutes. Thereafter, 2.5 g of propylene oxide was added dropwise in 5 minutes, and the mixture was heated to reflux for 1 hour.

이하 상법에 따라 처리하여, 생성되는 유상의 반응 생성물질을 에탄올 중에서 염산과 처리하여 염산염으로 하여 이소프로판올로 재결정한다.Treated according to the conventional method, the resulting oily reaction product is treated with hydrochloric acid in ethanol to be hydrochloride and recrystallized from isopropanol.

융점 212-215℃, 수득량 6.5gMelting point 212-215 ° C., yield 6.5 g

[실시예 8]

Figure kpo00007
Example 8
Figure kpo00007

에탄올 100ml 중에 금속 나트륨 1.36g을 용해하고 여기에 화합물(Ⅱ)의 염산염 10g을 가하여 30분간 교반한다. 후에 글리시들(2,3-에폭시-1-프로판올) 3.26g을 5분간에 적하하고, 2시간 가열 환류한다.1.36 g of metallic sodium is dissolved in 100 ml of ethanol, and 10 g of hydrochloride of compound (II) is added thereto, followed by stirring for 30 minutes. Thereafter, 3.26 g of glycidyl (2,3-epoxy-1-propanol) was added dropwise in 5 minutes, followed by heating to reflux for 2 hours.

이하 상법에 따라 처리하고, 염기성 물질을 n-부탄올로 추출하고, 추출물을 에탄올 염산과 처리하여 염산염으로 하고 에탄올로 재결정한다.Treated according to the conventional method, the basic material is extracted with n-butanol, the extract is treated with ethanol hydrochloric acid to be hydrochloride and recrystallized from ethanol.

융점 215-218℃, 수득량 6.8gMelting point 215-218 ° C., yield 6.8 g

[실시예 9]

Figure kpo00008
Example 9
Figure kpo00008

화합물(Ⅱ)의 염산염 10g 및 트리에틸아민 7.43g을 에탄올 50ml 중에서 30분간 가열 환류한다. 냉후 스틸렌옥사이드 5.25g을 5분간에 적하하고, 2분간 가열 환류한다. 이하 상법에 따라 처리하여 얻은 생성물을 실리카겔 크로마토그라피에서 정제하여, 염산염으로 하고 이소프로판올로 재결정한다.10 g of hydrochloride and 7.43 g of triethylamine of Compound (II) are heated to reflux for 30 minutes in 50 ml of ethanol. After cooling, 5.25 g of styrene oxide was added dropwise in 5 minutes, and heated to reflux for 2 minutes. The product obtained by treatment according to the conventional method is purified by silica gel chromatography, hydrochloride and recrystallized from isopropanol.

융점 170-173℃, 수득량 3.5gMelting Point 170-173 ° C, Yield 3.5g

반응 생성물 중에서 부반응 생성물로서 다음의 화학구조식(Ⅲ)으로 표시되는 물질도 동시에 수득된다.Among the reaction products, the material represented by the following chemical formula (III) as a side reaction product is also obtained at the same time.

융점(염산염) 177-182℃, 수득량 0.7gMelting point (hydrochloride) 177-182 ° C, yield 0.7g

Figure kpo00009
Figure kpo00009

[실시예 10]

Figure kpo00010
Example 10
Figure kpo00010

에탄올 10ml에 금속나트륨 0.14g을 용해하고, 화합물(Ⅱ) 염산염 2.0g을 가하고 30분간 교반한다. 그후 탄산칼륨 1.2g, 펜아실브로마이드 1.7g을 가하고, 1시간 교반 환류한다. 이하 상법에 의해 처리하여 유상의 반응 생성물 2.3g을 얻는다.0.14 g of metallic sodium is dissolved in 10 ml of ethanol, 2.0 g of compound (II) hydrochloride is added and stirred for 30 minutes. Then, 1.2 g of potassium carbonate and 1.7 g of penacylbromide are added, and the mixture is stirred and refluxed for 1 hour. By the following conventional method, 2.3g of oily reaction products are obtained.

이와같이 하여 얻은 N-펜아실제 2.3g을 그대로 메탄올 20ml 중에서 수소화 붕소 나트륨 300mg을 가하여 환원한다. 실온에서 1시간 교반후 상법에 따라 처리하고, 염산염으로 하여, 이소프로판올로 재결정한다.2.3 g of the N-phenacyl agent thus obtained is reduced by adding 300 mg of sodium borohydride in 20 ml of methanol as it is. After stirring for 1 hour at room temperature, the solution was treated according to a conventional method, and the mixture was recrystallized from isopropanol as hydrochloride.

융점 171-173℃, 수득량 1.5gMelting Point 171-173 ° C, Yield 1.5g

[실시예 11]

Figure kpo00011
Example 11
Figure kpo00011

화합물(Ⅱ)염산염 6.0g을 에탄올 100ml에 용해하고, 트리에틸아민 5.0g을 가하여 30분간 교반한다. 이것에 페닐글리시딜에테르 3.75g을 가하고 15분간 가열 환류한다. 이하 상법에 따라 처리하여 염산염으로 하고, 이소프로판올로 재결정한다. 융점 180-185℃, 수득량 5.1g6.0 g of compound (II) hydrochloride are dissolved in 100 ml of ethanol, 5.0 g of triethylamine is added, and the mixture is stirred for 30 minutes. 3.75 g of phenylglycidyl ethers are added to this and heated to reflux for 15 minutes. The solution is treated according to the conventional method to obtain hydrochloride, and recrystallized from isopropanol. Melting Point 180-185 ° C, Yield 5.1g

[실시예 12]

Figure kpo00012
Example 12
Figure kpo00012

화합물(Ⅱ) 염산염 3.4g을 알코올 20ml에 용해하고, 가성소다 1.2g, 에피클로로히드린 1g을 가하여 1시간 가열 환류한 후, 고형물을 여거한다. 알코올을 유거하고, 잔류물을 고도 감압 증류한다. 수득량 2.5gAfter dissolving 3.4 g of compound (II) hydrochloride in 20 ml of alcohol, 1.2 g of caustic soda and 1 g of epichlorohydrin were added and refluxed for 1 hour, the solid was filtered off. Alcohol is distilled off and the residue is distilled under high pressure. Yield 2.5 g

Claims (1)

다음 구조식(Ⅱ)의 트리메타디진을 에폭시 화합물과 반응시킴을 특징으로 하는 다음 구조식(I)의 트리메톡시벤질 피페라지노 에탄올 유도체의 제조방법.A process for preparing the trimethoxybenzyl piperazino ethanol derivative of the following formula (I) characterized by reacting the trimethadizine of the following formula (II) with an epoxy compound.
Figure kpo00013
Figure kpo00013
Figure kpo00014
Figure kpo00014
(식중, A는(Where A is
Figure kpo00015
Figure kpo00015
그중 X는 수소, 저급알킬기, 옥시메틸기, 페닐기 또는 펜옥시 메틸기임).X is hydrogen, lower alkyl group, oxymethyl group, phenyl group or phenoxy methyl group).
KR7601065A 1976-04-28 1976-04-28 Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives KR790001648B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7601065A KR790001648B1 (en) 1976-04-28 1976-04-28 Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7601065A KR790001648B1 (en) 1976-04-28 1976-04-28 Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives

Publications (1)

Publication Number Publication Date
KR790001648B1 true KR790001648B1 (en) 1979-12-01

Family

ID=19202225

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7601065A KR790001648B1 (en) 1976-04-28 1976-04-28 Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives

Country Status (1)

Country Link
KR (1) KR790001648B1 (en)

Similar Documents

Publication Publication Date Title
US4413142A (en) Method for preparing L-carnitine
JPH0245624B2 (en)
US4760182A (en) Process for preparing substituted phenol ethers via oxazolidine-structure intermediates
US4408063A (en) Preparation of epihalohydrin enantiomers
KR790001648B1 (en) Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives
US4588824A (en) Preparation of epihalohydrin enantiomers
US2937185A (en) Diamino alkanols and alkanones
US4346042A (en) Preparation of epihalohydrin enantiomers
EP0931055B1 (en) Selective alkylation of an alcohol substituted phenol compound
KR910000239B1 (en) Process for production of methyl 2-tetradecylgycidate
EP0125777B1 (en) Process and intermediates for preparation of 4-acetyl-2-substituted-imidazoles
EP0104403B1 (en) New method for the synthesis of 5-thio-1,2,3-thiadiazole
US4418193A (en) Method of producing 2-epi-fortimicin A
FR2493316A1 (en) NEW PROCESS FOR THE PREPARATION OF (TRIALCOXY BENZYL) -1 PIPERAZINES AND IN PARTICULAR (TRIMETHOXY-2 ', 3', 4 'BENZYL) -1 PIPERAZINE
JP3081854B2 (en) Method for producing optically active levobunolol synthetic intermediate
US3751462A (en) Process for preparation of substituted fluoromethanesulfonanilides
JPS5914031B2 (en) Trimethoxybenzylpiperazinoethanol derivative
WO2006031179A1 (en) Process for preparation of phtalimide
US5081268A (en) Process for the preparation of oxetanes from 1,3-glycol monosulfates
JPH0637449B2 (en) Process for producing optically active atenolol and its intermediates
KR880002619B1 (en) Process for the preparation of metoprolol
KR900000969B1 (en) Process for the preparation of 2-(7'-theophylline methyl)-1,3-dioxolan
EP0058071B1 (en) Process and intermediates for preparing pirbuterol
KR860000624B1 (en) Process for preparing pirbuterol and analogs
JPS6126902B2 (en)